This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Sqz Biotechnologies Company. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Katherine Seidl - Innovator in Cancer Research
Introduction
Katherine Seidl is an accomplished inventor based in Watertown, MA (US). She currently works at Stemcell Technologies Canada Inc. Although she has not yet been granted any patents, her work focuses on innovative methods to stimulate immune responses in cancer treatment.
Latest Patent Applications
Katherine's latest patent applications include:
1. **Methods to Stimulate Immune Responses to Mutant Ras Using Anucleate Cells** - This application provides anucleate cells comprising a mutated Ras antigen, such as a mutated K-Ras antigen. It details methods of manufacturing these anucleate cells and their use in stimulating an immune response, treating, and vaccinating individuals with cancers associated with Ras mutations.
2. **Methods to Stimulate Immune Responses to Mutant Ras Using Nucleated Cells** - This application outlines nucleated cells that include a mutated Ras antigen. It describes methods for manufacturing these nucleated cells and their application in stimulating immune responses, treating, and vaccinating individuals with cancers linked to Ras mutations.
Conclusion
Katherine Seidl is making significant strides in cancer research through her innovative approaches to immune response stimulation. Her contributions have the potential to impact cancer treatment significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile